Showing 5201-5210 of 8785 results for "".
- Burt's Bees Data at WCD Highlights Power of Naturalshttps://practicaldermatology.com/news/burts-bees-data-at-wcd-highlights-power-of-naturals/2460062/New research from Burt's Bees supports findings related to the skin's composition and the role of nature-based regimens to protect the skin against common environmental stressors. The studies will be presented at the 24th World Congress of Dermatology (WCD) Meeting in Milan
- Derm Residents Optimize Total Skin Exams Using Bioengineering Principleshttps://practicaldermatology.com/news/derm-residents-optimize-total-skin-exams-using-bioengineering-principles/2460058/Researchers at the Penn State Health Milton S. Hershey Medical Center are using engineering principles to improve the accuracy and efficiency of total body skin exams. There is no standardized method for performing a total body skin exam. D
- Pivotal Phase 3 Trials of Trifarotene in Patients with Moderate Facial and Truncal Acne Meet All Efficacy Endpointshttps://practicaldermatology.com/news/pivotal-phase-3-trials-of-trifarotene-in-patients-with-moderate-facial-and-truncal-acne-meet-all-efficacy-endpoints-2/2460056/Results from the pivotal Phase 3 PERFECT 1 and PERFECT 2 clinical trials of once-daily trifarotene 50 µg/g cream in patients with moderate acne on the face and trunk, published in the June issue of Journal of the American Academy of Dermatology, met all primary and secondary efficacy endpoi
- Sciton Promotes Two Leadershttps://practicaldermatology.com/news/sciton-promotes-two-leaders/2460050/Bryant Wong is the new Vice President of Finance at Sciton and Emma Haaland is the new Global Director of Customer Service. Mr. Wong spent two years as the leader of the finance department at Sciton. He worked for nearly 12 years with PricewaterhouseCoopers and Deloitte C
- New NRS Study Shows Positive Impact of Clear Skin in Rosacea Patientshttps://practicaldermatology.com/news/new-nrs-study-shows-positive-impact-of-clear-skin-in-rosacea-patients/2460048/Treating rosacea can have a major positive impact on patients’ lives, according to a new survey by the National Rosacea Society. In the survey of 1,044 rosacea patients, around 76 percent of all respondents saw at least some improvement in th
- Galderma Partners with Three Charitieshttps://practicaldermatology.com/news/galderma-partners-with-three-charities/2460047/Galderma is partnering with
- Laser Microscope Can Diagnose Skin Cancer and Perform Surgeryhttps://practicaldermatology.com/news/specialized-microscope-can-diagnose-skin-cancer-and-perform-surgery/2460045/University of British Columbia researchers have developed a specialized microscope that has the potential ability to both diagnose diseases including skin cancer and perform incredibly precise surgery--all without cutting skin. The researchers describe the technology in
- Positive 90-Day Results from CONFORM Study: Recros Medicahttps://practicaldermatology.com/news/positive-90-day-results-from-conform-study-recros-medica/2460042/Ninety-day results from the CONFORM study assessing the efficacy, safety, and patient satisfaction of the Rotational Fractional Resection (RFR) procedure for submental contouring are promising. RFR is a novel, proprietary alternative to traditional approaches to treat skin laxity developed by
- Crown Laboratories Adds to Portfoliohttps://practicaldermatology.com/news/crown-laboratories-adds-to-portfolio/2460040/On the heels of a brand relaunch this week,Crown Laboratories’ Aesthetics division, Bellus Medical, has acquired the HD PRP system for the aesthetic marketplace from Healeon Medical, Inc. The system is designed to meet the demands of busy practices seeking higher volume and higher yiel
- FDA Approves Sorilux for Adolescent Plaque Psoriasishttps://practicaldermatology.com/news/fda-approves-sorilux-for-adolescent-plaque-psoriasis/2460039/The FDA has approved Mayne Pharma Group Limited's Sorilux (calcipotriene) Foam, 0.005% in adolescents 12 years and older. The FDA approved Sorilux in 2010 based on evidence from two eight-week placebo controlled clinical trials in patients with mild to moderate plaque psoriasis of t